Journal Club Papers
- Unexpected CDH1 Mutations Identified on Multigene Panels Pose Clinical Management Challenges
- Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making
- Circulating Tumor DNA in Non–Small-Cell Lung Cancer: A Primer for the Clinician
- Communicating About Precision Oncology
- Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma.
- Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers.
- Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data.
- Immune Checkpoint Blockade in PD-L1-Positive Platinum-Refractory Cervical Carcinoma.
- Advanced Epithelial Ovarian Cancer: Do More Options Mean Greater Benefits?
- Challenge of Rechallenge: When to Resume Immunotherapy Following an Immune-Related Adverse Event.
- How We Approach Smoldering Multiple Myeloma
- Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
- Multidisciplinary Management of Breast Cancer With Extensive Regional Nodal Involvement.
- Management of Women With Breast Cancer and Pathogenic Variants in Genes Other Than BRCA1 or BRCA2.
- Should Everyone With Ductal Carcinoma in Situ Receive Adjuvant Radiation?
- Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804.
- Achieving a Cure Without Total Mesorectal Excision in Rectal Adenocarcinoma.
- Neoadjuvant Chemotherapy, Excision, and Observation for Early Rectal Cancer: The Phase II NEO Trial (CCTG CO.28) Primary End Point Results.
